Lewington A, MacTier R, Hoefield R, Sutton A, Smith D, Downes M. Prevention of contrast induced acute kidney injury (CI-AKI) in adult patients. On behalf of the Renal Association, British Cardiovascular Intervention Society and The Royal College of Radiologists, 2013. Available at:http://www.renal.org/docs/default-source/guidelines-resources/ joint-guidelines/Prevention_of_Contrast_Induced_Acute_Kidney_Injury_CI-AKI_In_Adult_Patients.pdf.

Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int Suppl 2012;2:69–88.

Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989;36:730–740.

Gong X, Duan Y, Zheng J, Wang Y, Wang G, Norgren S, et al. Nephroprotective effects of N-acetylcysteine amide against contrast-induced nephropathy through upregulating thioredoxin-1, inhibiting ASK1/p38MAPK pathway, and suppressing oxidative stress and apoptosis in rats. Oxid Med Cell Longev 2016;2016:8715185.

Efferth T, Li PC, Konkimalla VB, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007;13:353–361.

Zhao K, Li Y, Zhang H. Role of Dongchongxiacao (Cordyceps) in prevention of contrast-induced nephropathy in patients with stable angina pectoris. J Tradit Chin Med 2013;33:283–286.

Zhao K, Lin Y, Li Y, Gao S. Efficay of short-term cordyceps sinensis for prevention of contrast-induced nephropathy in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention. Int J Clin Exp Med 2014;7:5758–5764.

Yamaguchi Y, Kagota S, Nakamura K, Shinozuka K, Kunitomo M. Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis. Phytother Res 2000;14:647–649.

Huang J, Yuan M, Ma J, Liu R, Dong Z, Zhao G, et al. Protective effects of salvianolate on contrast-induced nephropathy after primary percutaneous coronary intervention: a prospective multicenter randomized controlled trial. Cardiology 2017;138:169–178.

Ozkan G, Ulusoy S, Orem A, Ersoz S, Alkanat M, Yucesan FB, et al. Protective effect of the grape seed proanthocyanidin extract in a rat model of contrast-induced nephropathy. Kidney Blood Press Res 2012;35:445–453.

Gong X, Wang Q, Tang X, Wang Y, Fu D, Lu H, et al. Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways. Am J Nephrol 2013;37:199–207.

Chu SC, Hu LH, Wang XL, Sun SQ, Zhang T, Sun Z, et al. Xuezhikang ameliorates contrast media-induced nephropathy in rats via suppression of oxidative stress, inflammatory responses and apoptosis. Renal Failure 2016;38:1717–1725.

Ulusoy S, Ozkan G, Mungan S, Yucesan FB. GSPE is superior to NAC in the prevention of contrast-induced nephropathy: might this superiority be related to caspase 1 and calpain 1? Life Sci 2014;103:101–110.

Kitano H. Computational systems biology. Nature 2002;420:206–210.

Jiang W. Therapeutic wisdom in tradtional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci 2005;26:558–563.

Konkimalla VB, Efferth T. Evidence-based Chinese medicine for cancer therapy. J Ethnopharmacol 2008;116:207–210.

Wang M, Xie T, Chang Z, Wang L, Xie X, Kou Y, et al. A new type of liquid silymarin proliposome containing bile salts: its preparation and improved hepatoprotective effects. PLoS ONE 2015;10(12): e0143625.